Your Journey Starts Here,
Welcome to Afigen – Shaping the Future of Biotechnology !
Afigen is a pioneering biotechnology company dedicated to advancing human health through innovative solutions and high-quality products. Specializing in recombinant proteins, diagnostics, and therapeutic research, we provide essential tools and services that support both scientific research and clinical diagnostics. Our mission is to accelerate medical research, improve disease detection, and contribute to the development of cutting-edge treatments, making Afigen a trusted name in the biotechnology field.
At Afigen, we understand that biotechnology is constantly evolving, which is why we focus on delivering flexible, customizable, and scalable solutions to meet the diverse needs of researchers, healthcare professionals, and pharmaceutical companies. With an unwavering commitment to excellence, we bring together top-tier talent, state-of-the-art technologies, and industry best practices to solve some of the most pressing challenges in the healthcare sector.
Why Choose Afigen?
Afigen combines a wealth of industry knowledge, cutting-edge technology, and a dedication to quality to deliver biotechnology solutions that meet the highest scientific standards. Whether you are a researcher, clinician, or patient, Afigen offers a variety of products and services designed to facilitate the advancement of your work and improve patient outcomes. Here’s why you should choose Afigen:

Customizable Solutions: Understanding that each research or clinical application has unique requirements, we offer tailored solutions to meet your specific needs.

Expert Support:
Our team of seasoned experts is available to provide technical guidance, troubleshooting, and ongoing support to ensure the success of your projects.

Unmatched Quality:
We ensure that every product, from recombinant proteins to diagnostic kits, undergoes rigorous testing to guarantee its purity, efficacy, and reliability.
Recombinant Proteins:
At Afigen, we offer a broad spectrum of recombinant proteins, from enzymes to antibodies, carefully crafted using state-of-the-art biotechnology processes. These proteins are essential for a range of applications, including drug discovery, diagnostics, and therapeutic research. Our recombinant proteins are produced with high specificity, ensuring they meet the stringent standards required for research and clinical use.
Advanced Diagnostic Solutions:
We understand that accurate, reliable diagnostics are critical for patient care. Afigen provides innovative diagnostic tools such as enzyme-linked immunosorbent assays (ELISA), polymerase chain reaction (PCR) kits, and other advanced detection methods. These tools help healthcare providers identify diseases quickly and accurately, allowing for more effective treatment planning. Our diagnostic solutions are designed to assist in both the early detection of diseases and the monitoring of treatment outcomes.

Commitment to Quality and Compliance
At Afigen, we adhere to the highest standards of quality control to ensure that every product meets global regulatory requirements. We work closely with regulatory bodies such as the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and other international health authorities to ensure compliance with safety and efficacy standards. All of our products undergo extensive testing, including in vitro and in vivo validation, to ensure they meet the performance requirements for both research and clinical use.
We are committed to continuous improvement and innovation, ensuring that our offerings remain at the cutting edge of biotechnology. By implementing best practices in manufacturing, testing, and distribution, we maintain the trust of our partners and clients worldwide.
tDenHyb™ Trial Set and cDenHyb™ Trial Set, including relevant peer-reviewed references and links to .gov and .edu sources such as NCBI and PubMed that validate the use of FISH hybridization buffers in formalin-fixed paraffin-embedded (FFPE) tissues and cell samples.
🔬 tDenHyb™ Trial Set – Optimized Tissue Hybridization Buffers for FISH
Catalog No.: INS-D105
Contents:
- 0.50 ml tDenHyb-1
- 0.50 ml tDenHyb-2
The tDenHyb™ Trial Set is designed to evaluate hybridization efficiency in formalin-fixed paraffin-embedded (FFPE) tissue samples for fluorescence in situ hybridization (FISH). Each component enhances probe-target binding efficiency under varying sequence complexities.
🧪 Component Descriptions:
-
tDenHyb-1:
Optimized for centromeric and repetitive sequence probes. Its formulation is tailored for increased signal intensity in low-complexity genomic regions.
🔍 Related Research:- Wilhelm-Benartzi et al., 2011 – Discusses epigenetic profiling in FFPE tissue using repeat sequence probes.
- Shaffer et al., 2004 – Demonstrates the application of FISH for centromeric enumeration in clinical diagnostics.
-
tDenHyb-2:
Developed to improve hybridization with unique sequence DNA probes. Particularly effective for detecting gene-specific targets or low-copy genomic regions in FFPE specimens.
🔍 Related Research:- Tanke et al., 2002 – Covers hybridization parameters for unique sequences using tissue FISH.
- Volpi et al., 2000 – Validates the efficiency of different denaturation and hybridization protocols for unique genomic targets.
🧬 cDenHyb™ Trial Set – Optimized Cell Hybridization Buffers for FISH
Catalog No.: INS-D005
Contents:
- 0.50 ml cDenHyb-1
- 0.50 ml cDenHyb-2
Designed for cell-based FISH applications, the cDenHyb™ Trial Set provides distinct hybridization solutions depending on the target probe sequence. It is especially relevant for interphase and metaphase chromosomal studies in cultured cells.
🧪 Component Descriptions:
-
cDenHyb-1:
A general-purpose hybridization buffer suitable for repetitive DNA probes and chromosome paints. Effective for classic cytogenetic applications.
🔍 Related Research:- Lichter et al., 1990 – A landmark study on using FISH with repetitive DNA probes in cell samples.
- Trask et al., 1991 – Showcases whole-chromosome painting and the role of hybridization buffers.
-
cDenHyb-2:
Specifically formulated for unique sequence probes in cell samples, this solution provides optimal conditions for gene-specific FISH signals, particularly in gene mapping or translocation detection.
🔍 Related Research:- Zhang et al., 1997 – Evaluates buffer effects on hybridization stringency for unique probe detection.
- Speicher et al., 1996 – Highlights importance of buffer conditions in multicolor FISH protocols.
🔎 Additional Resources & Protocol Guidance:
- NIH Assay Guidance Manual: NCBI Bookshelf
- Detailed FISH Protocols: Protocols.io - FISH
- Overview of FISH in Pathology: NIH Cancer.gov – FISH Use in Tumor Diagnostics
Summary
Buffer | Optimized For | Application | Reference |
---|---|---|---|
tDenHyb-1 | Repetitive/Centromeric probes | FFPE Tissue | Shaffer 2004 |
tDenHyb-2 | Unique sequence probes | FFPE Tissue | Volpi 2000 |
cDenHyb-1 | Repetitive probes | Cells (interphase/metaphase) | Lichter 1990 |
cDenHyb-2 | Unique sequence probes | Cells | Speicher 1996 |
Innovative Solutions for the Future of Healthcare
Afigen is dedicated to transforming the future of healthcare through biotechnology. We work closely with academic researchers, healthcare providers, and pharmaceutical companies to deliver products that not only address current healthcare challenges but also anticipate the needs of tomorrow. Our work spans a wide range of therapeutic areas, from oncology and immunology to infectious diseases and genetic disorders, ensuring that our solutions have a broad impact.
We are committed to bringing breakthrough therapies to the market faster and more efficiently, helping to accelerate the development of new treatments and improving patient outcomes globally. By integrating cutting-edge technology with scientific expertise, Afigen is poised to lead the way in the next generation of healthcare solutions.
